Cita APA (7a ed.)

Zou, F., Lu, L., Liu, J., Xia, B., Zhang, W., Hu, Q., . . . Zhang, H. (2019). Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nature Portfolio.

Cita Chicago Style (17a ed.)

Zou, Fan, et al. Engineered Triple Inhibitory Receptor Resistance Improves Anti-tumor CAR-T Cell Performance via CD56. Nature Portfolio, 2019.

Cita MLA (8a ed.)

Zou, Fan, et al. Engineered Triple Inhibitory Receptor Resistance Improves Anti-tumor CAR-T Cell Performance via CD56. Nature Portfolio, 2019.